Progression of glomerular diseases: is the podocyte the culprit? - PubMed (original) (raw)
Review
Progression of glomerular diseases: is the podocyte the culprit?
W Kriz et al. Kidney Int. 1998 Sep.
Free article
Abstract
The stereotyped development of the glomerular lesions in many animal models and human forms of progressive renal disease suggests that there are common mechanisms of disease progression. We propose the outline of such a mechanism based on following aspects: (1) The glomerulus is a complex structure, the stability of which depends on the cooperative function of the basement membrane, mesangial cells and podocytes, counteracting the distending forces originating from the high glomerular hydrostatic pressures. Failure of this system leads to quite uniform architectural lesions. (2) There is strong evidence that the podocyte is incapable of regenerative replication post-natally; when podocytes are lost for any reason they cannot be replaced by new cells. Loss of podocytes may therefore lead to areas of "bare" GBM. which represent potential starting points for irreversible glomerular injury. (3) Attachment of parietal epithelial cells to bare GBM invariably occurs when bare GBM coexists with architectural lesions, leading to the formation of a tuft adhesion to Bowman's capsule, the first "committed" lesion progressing to segmental sclerosis. (4) Within an adhesion the tuft merges with the interstitium, allowing filtration from perfused capillaries inside the adhesion towards the interstitium. The relevance of such filtration is as yet unclear but may play a considerable role in progression to global sclerosis and interstitial fibrosis.
Similar articles
- Pathways to nephron loss starting from glomerular diseases-insights from animal models.
Kriz W, LeHir M. Kriz W, et al. Kidney Int. 2005 Feb;67(2):404-19. doi: 10.1111/j.1523-1755.2005.67097.x. Kidney Int. 2005. PMID: 15673288 Review. - Glomerular damage after uninephrectomy in young rats. II. Mechanical stress on podocytes as a pathway to sclerosis.
Nagata M, Kriz W. Nagata M, et al. Kidney Int. 1992 Jul;42(1):148-60. doi: 10.1038/ki.1992.272. Kidney Int. 1992. PMID: 1635344 - How does podocyte damage result in tubular damage?
Kriz W, Elger M, Hosser H, Hähnel B, Provoost A, Kränzlin B, Gretz N. Kriz W, et al. Kidney Blood Press Res. 1999;22(1-2):26-36. doi: 10.1159/000025906. Kidney Blood Press Res. 1999. PMID: 10352405 Review. - The development of focal segmental glomerulosclerosis in masugi nephritis is based on progressive podocyte damage.
Shirato I, Hosser H, Kimura K, Sakai T, Tomino Y, Kriz W. Shirato I, et al. Virchows Arch. 1996 Nov;429(4-5):255-73. doi: 10.1007/BF00198342. Virchows Arch. 1996. PMID: 8972762 - From segmental glomerulosclerosis to total nephron degeneration and interstitial fibrosis: a histopathological study in rat models and human glomerulopathies.
Kriz W, Hosser H, Hähnel B, Gretz N, Provoost AP. Kriz W, et al. Nephrol Dial Transplant. 1998 Nov;13(11):2781-98. doi: 10.1093/ndt/13.11.2781. Nephrol Dial Transplant. 1998. PMID: 9829480
Cited by
- Extracellular signal-regulated kinase is activated in podocytes from patients with diabetic nephropathy.
Yamashiro A, Satoh Y, Endo S, Oshima N. Yamashiro A, et al. Hum Cell. 2024 Sep;37(5):1553-1558. doi: 10.1007/s13577-024-01108-4. Epub 2024 Jul 25. Hum Cell. 2024. PMID: 39052150 - Screening impacts of Tilmicosin-induced hepatic and renal toxicity in rats: protection by Rhodiola rosea extract through the involvement of oxidative stress, antioxidants, and inflammatory cytokines biomarkers.
Elgendy SA, Soliman MM, Shukry M, Mohammed LA, Nasr HE, Althobaiti S, Almalki DA, Alotaibi KS, Albattal SB, Elnoury HA. Elgendy SA, et al. Naunyn Schmiedebergs Arch Pharmacol. 2024 Oct;397(10):7623-7637. doi: 10.1007/s00210-024-03089-5. Epub 2024 Apr 30. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38689072 - Obesity-related glomerulopathy is associated with elevated WT1 expression in podocytes.
Jakhotia S, Kavvuri R, Raviraj S, Baishya S, Pasupulati AK, Reddy GB. Jakhotia S, et al. Int J Obes (Lond). 2024 Aug;48(8):1080-1091. doi: 10.1038/s41366-024-01509-3. Epub 2024 Mar 19. Int J Obes (Lond). 2024. PMID: 38504059 - Urinary podocyte markers of disease activity, therapeutic efficacy, and long-term outcomes in acute and chronic kidney diseases.
Fukuda A, Sato Y, Shibata H, Fujimoto S, Wiggins RC. Fukuda A, et al. Clin Exp Nephrol. 2024 Jun;28(6):496-504. doi: 10.1007/s10157-024-02465-y. Epub 2024 Feb 25. Clin Exp Nephrol. 2024. PMID: 38402504 Free PMC article. Review. - tRNA-Derived Small RNAs: A Novel Regulatory Small Noncoding RNA in Renal Diseases.
Li D, Xie X, Yin N, Wu X, Yi B, Zhang H, Zhang W. Li D, et al. Kidney Dis (Basel). 2023 Sep 13;10(1):1-11. doi: 10.1159/000533811. eCollection 2024 Feb. Kidney Dis (Basel). 2023. PMID: 38322624 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical